World's Best Scientists 2026 revealed!
Award Badge
Microbiology
USA
2026

D-Index & Metrics

Microbiology

D-Index
137
Citations
77903
World Ranking
59
National Ranking
29

Medicine

D-Index
138
Citations
78770
World Ranking
1819
National Ranking
1037

Dimitrios P. Kontoyiannis publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Dimitrios P. Kontoyiannis sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 763 publications — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Dimitrios P. Kontoyiannis D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Dimitrios P. Kontoyiannis sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 137 D-Index — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Microbiology in United States Leader Award
  • 2025 - Research.com Microbiology in United States Leader Award
  • 2017 - Fellow of the American Association for the Advancement of Science (AAAS)
  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Member of the European Academy of Sciences and Arts
  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Member of the European Academy of Sciences and Arts
  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Member of the European Academy of Sciences and Arts
  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Member of the European Academy of Sciences and Arts
  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Member of the European Academy of Sciences and Arts
  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Member of the European Academy of Sciences and Arts
  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Member of the European Academy of Sciences and Arts
  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Member of the European Academy of Sciences and Arts

Overview

Dimitrios P. Kontoyiannis is a researcher affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their academic work primarily focuses on medicine, with extensive contributions in epidemiology, infectious diseases, oncology, pulmonary and respiratory medicine, and immunology. The research spans various aspects of fungal infections, antifungal resistance, and cancer-related infectious complications.

The scientist has published significant research on topics such as:

  • Antifungal resistance and susceptibility
  • Fungal infections and studies
  • Neutropenia and cancer infections
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Nail diseases and treatments
  • Infectious diseases and mycology
  • Plant pathogens and fungal diseases

Their frequently published venues include:

  • Open Forum Infectious Diseases
  • Journal of Fungi
  • Clinical Infectious Diseases
  • The Journal of Infectious Diseases
  • mBio

Dimitrios P. Kontoyiannis has collaborated extensively with co-authors such as Sebastian Wurster, Nathaniel D. Albert, Takahiro Matsuo, Ying Jiang, and Russell E. Lewis.

Notable recent publications include:

  • When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis, 2021, Journal of Fungi
  • Epidemiology and Organ Specific Sequelae of Post-Acute COVID-19: A Narrative Review, 2021, Journal of Infection
  • Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium, 2020, The Journal of Infectious Diseases
  • Impact of Climate Change and Natural Disasters on Fungal Infections, 2024, The Lancet Microbe
  • Environmental Candida auris and the Global Warming Emergence Hypothesis, 2021, mBio

Their work lies at the intersection of clinical infectious diseases and mycology, with significant attention to the effects of environmental factors and underlying conditions on fungal infections.

Dimitrios P. Kontoyiannis is recognized as a Fellow of the American Association for the Advancement of Science (AAAS) since 2017 and also holds fellowships and memberships in European scientific organizations, including the European Confederation of Medical Mycology and the European Academy of Sciences and Arts.

Best Publications

  • Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

    Thomas J. Walsh;Elias J. Anaissie;David W. Denning;Raoul Herbrecht

  • Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases

    Maureen M. Roden;Theoklis E. Zaoutis;Wendy L. Buchanan;Tena A. Knudsen

  • Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America

    Thomas F. Patterson;George Richard Thompson;David W. Denning;Jay A. Fishman

  • Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

    J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach

  • Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database

    Dimitrios P. Kontoyiennis;Kieren A. Marr;Benjamin J. Park;Barbara D. Alexander

  • Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)

    Peter G. Pappas;Barbara D. Alexander;David R. Andes;Susan Hadley

  • Epidemiology and Clinical Manifestations of Mucormycosis

    George Petrikkos;Anna Skiada;Olivier Lortholary;Emmanuel Roilides

  • Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

    Johan A. Maertens;Issam I. Raad;Kieren A. Marr;Thomas F. Patterson

  • Delaying Amphotericin B–Based Frontline Therapy Significantly Increases Mortality among Patients with Hematologic Malignancy Who Have Zygomycosis

    Georgios Chamilos;Russell E. Lewis;Russell E. Lewis;Dimitrios P. Kontoyiannis

  • Pathogenesis of Mucormycosis

    Ashraf S. Ibrahim;Brad Spellberg;Thomas J. Walsh;Dimitrios P. Kontoyiannis

  • Zygomycosis in a Tertiary-Care Cancer Center in the Era of Aspergillus-Active Antifungal Therapy: A Case-Control Observational Study of 27 Recent Cases

    Dimitrios P Kontoyiannis;Michail S. Lionakis;Russell E. Lewis;Russell E. Lewis;Georgios Chamilos

  • Glucocorticoids and invasive fungal infections.

    Michail S Lionakis;Dimitrios P Kontoyiannis

  • Posaconazole Is Effective as Salvage Therapy in Zygomycosis: A Retrospective Summary of 91 Cases

    Jo Anne H. van Burik;Roberta S. Hare;Howard F. Solomon;Michael L. Corrado

  • Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003).

    Georgios Chamilos;Mario Luna;Russell E. Lewis;Russell E. Lewis;Gerald P. Bodey

  • Zygomycosis in the 1990s in a Tertiary-Care Cancer Center

    Dimitrios P. Kontoyiannis;Verena C. Wessel;Gerald P. Bodey;Kenneth V. I. Rolston

  • Recent Advances in the Management of Mucormycosis: From Bench to Bedside

    Brad Spellberg;Thomas J. Walsh;Dimitrios P. Kontoyiannis;J. John Edwards

  • Antifungal drug resistance of pathogenic fungi

    Dimitrios P Kontoyiannis;Russell E Lewis

  • Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

    Brahm H. Segal;Raoul Herbrecht;David A. Stevens;David A. Stevens;Luis Ostrosky-Zeichner

  • Combination antifungal therapy for invasive aspergillosis a randomized trial

    Kieren A. Marr;Haran T. Schlamm;Raoul Herbrecht;Scott T. Rottinghaus

  • Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program

    J. Morgan;K. A. Wannemuehler;K. A. Marr;S. Hadley

Frequent Co-Authors

Russell E. Lewis
Russell E. Lewis University of Padua
Issam I Raad
Issam I Raad The University of Texas MD Anderson Cancer Center
Thomas J. Walsh
Thomas J. Walsh Weill Cornell Medicine
Jeffrey J Tarrand
Jeffrey J Tarrand The University of Texas MD Anderson Cancer Center
Georgios Chamilos
Georgios Chamilos University of Crete
Ray Y Hachem
Ray Y Hachem The University of Texas MD Anderson Cancer Center
Emmanuel Roilides
Emmanuel Roilides Aristotle University of Thessaloniki
Michail S. Lionakis
Michail S. Lionakis National Institute of Allergy and Infectious Diseases
Kenneth V. I. Rolston
Kenneth V. I. Rolston The University of Texas MD Anderson Cancer Center
Gerald P. Bodey
Gerald P. Bodey The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to a variety of interdisciplinary career paths, particularly within the healthcare and information management sectors. For those interested in healthcare administration, pursuing a health information management degree salary can be a lucrative option, offering roles that blend biology knowledge with data and administrative skills.

Prospective students can find reputable programs through a cahiim accredited him degree online, ensuring their education meets industry standards and prepares them for certification.

Another promising avenue is healthcare coding and billing, where professionals manage patient data and billing processes. Certifications such as certified professional coder (cpc) help individuals validate their expertise and enhance job prospects. Additionally, accelerated training options like the medical billing and coding certificate online accelerated programs allow for quicker entry into the workforce.

Overall, microbiology graduates equipped with complementary skills in health information and coding are well-positioned to thrive in today's evolving healthcare landscape.

Best Scientists Citing Dimitrios P. Kontoyiannis

Trending Scientists